Detection of trichloroethylene-protein adducts in rat liver and plasma

Toxicology Letters

Volumn 92, Issue 3, 1997, Pages 187-194

  Halmes, N Christine ^a   Perkins, Everett J ^a   McMillan, David C ^b   Pumford, Neil R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autoimmunity; Cancer; Cytochrome P450 2E1; Human; Protein adduct; Rat; Toxicity; Trichloroethylene (1,1,2 trichloroethene)

Indexed keywords

CYTOCHROME P450 ISOENZYME; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; COVALENT BOND; LIVER; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALS; AUTOIMMUNITY; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; ENVIRONMENTAL POLLUTANTS; LIVER; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TRICHLOROETHYLENE;

ANIMALIA;

EID: 0030775436     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00053-2     Document Type: Article

References (34)

1. Allemand, H., Pessayre, D., Descatoire, V., Degott, C., Feldmann, G., Benhamou, J.P., 1978. Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver. J. Pharmacol. Exp. Ther. 204, 714-723.
2. Beaune, P., Dansette, P.M., Mansuy, D., Kiffel, L., Finck, M., Amar, C., Leroux, J.P., Homberg, J.C., 1987. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc. Natl Acad. Sci. USA 84, 551-555.
3. Bourdi, M., Chen, W., Peter, R.M., Martin, J.L., Buters, J.T.M., Nelson, S.D., Pohl, L.R., 1996. Human P4502E1 is a major autoantigen associated with halothane hepatitis and the epitopes are conformational. Chem. Res. Toxicol. 9, 1159-1166.
4. Bove, F.J., Fulcomer, M.C., Klotz, J.B., Esmart, J., Dufficy, E.M., Savrin, J.E., 1995. Public drinking water contamination and birth outcomes. Am. J. Epidem. 141, 850-862.
5. Bruckner, J.V., Davis, B.D., Blancato, J.N., 1989. Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol 20, 31-50.
6. Cutler, J.J., Parker, G.S., Rosen, S., Prenney, B., Healey, R., Caldwell, G.G., 1986. Childhood leukemia in Woburn, Massachusetts. Public Health Rep. 101, 201-205.
7. Dansette, P.M., Amar, C., Valadon, P., Pons, C., Beaune, P.H., Mansuy, D., 1991. Hydroxylation and formation of electrophilic metabolises of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation. Biochem. Pharmacol. 41, 553-560.
8. Davidson, I.W., Beliles, R.P., 1991. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23, 493-599.
9. Eliasson, E., Kenna, J.G., 1996. Cytochrome P450 2E1 is a cell surface autoantigen in halothane. Molecular Pharmacol. 50, 573-582.
10. Eliasson, E., Johansson, I., Ingelman-Sundberg, M., 1988. Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures. Biochem. Biophys. Res. Commun. 150, 436-443.
11. Fisher, J.W., 1993. Estimating the risks of liver and lung cancer in humans exposed to trichloroethylene using a physiological model. Toxicol. Lett. 68, 127-129.
12. Goeptar, A.R., Commandeur, J.N.M., van Ommen, B., van Bladeren, P.J., Vermeulen, N.P.E., 1995. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem. Res. Toxicol. 8, 3-21.
13. Halmes, N.C., McMillan, D.C., Oatis, J.E. Jr., Pumford, N.R., 1996. Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem. Res. Toxicol. 9, 451-456.
14. Halmes, N.C., Samokyszyn, V.M., Pumford, N.R., 1997. Covalent binding and inhibition of cytochrome P4502E1 by trichloroethylene. Xenobiotica 27, 101-110.
15. 2) in tienilic acid-induced hepatitis. Clin. Exp. Immunol. 55, 561-570.
16. IARC, 1995, Vol. 63, World Health Organization, International Agency for Research on Cancer, Lyon, France, pp. 75-158.
17. Johansson, I., Ekstrom, G., Scholte, B., Puzycki, D., Jornvall, H., Ingelman-Sundberg, M., 1988. Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry 27, 1925-1934.
18. Khan, M.F., Kaphalia, B.S., Prabhakar, B.S., Kanz, M.F., Ansari, G.A., 1995. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol. Appl. Pharmacol. 134, 155-160.
19. Kilburn, K.H., Warshaw, R.H., 1992. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ. Res. 57, 1-9.
20. Lecoeur, S., Bonierbale, E., Challine, D., Gautier, J.C., Valadon, P., Dansette, P.M., Catinot, R., Ballet, F., Mansuy, D., Beaune, P.H., 1994. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7, 434-442.
21. Lockey, J.E., Kelly, C.R., Cannon, G.W., Colby, T.V., Aldrich. V., Livingston, G.K., 1987. Progressive systemic sclerosis associated with exposure to trichloroethylene. J. Occup. Med. 29, 493-496.
22. Lopez-Garcia, M.P., Dansette, P.M., Mansuy, D., 1994. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P450: inactivation of yeast expressed human liver cytochrome P450 2C9 by tienilic acid. Biochemistry 33, 166-175.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Miller, R.E., Guengerich, F.P., 1982. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21, 1090-1097.
25. Miller, R.E., Guengerich, F.P., 1983. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450. Cancer Res. 43, 1145-1152.
26. Phoon, W.H., Chan, M.O., Rajan, V.S., Tan, K.J., Thirumoorthy, T., Goh, C.L., 1984. Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene. Con. Dermatitis 10, 270-276.
27. Pohl, L.R., Pumford, N.R., Martin, J.L., 1996. Mechanisms, chemical structures, and drug metabolism. Eur. J. Haematol. 57 (suppl), 98-104.
28. Pohl, L.R., 1990. Drug-induced allergic hepatitis.. Sem. Liver Dis. 10, 305-315.
29. Pumford, N.R., Hinson, J.A., Benson, R.W., Roberts, D.W., 1990a. Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol. Appl. Pharmacol. 104, 521-532.
30. Pumford, N.R., Roberts, D.W., Benson, R.W., Hinson, J.A., 1990b. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem. Pharmacol, 40, 573-579.
31. Pumford, N.R., Martin, B.M., Thomassen, D., Burris, J.A., Kenna, J.G., Martin, J.L., Pohl, L.R., 1993. Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72. Chem. Res. Toxicol. 6, 609-615.
32. Stevens, O.K., Eyre, R.J., Bull, R.J., 1992. Adduction of hemoglobin and albumin in vivo by metabolises of trichloroethylene, trichloroacetate, and dichloroacetate in rats and mice. Fundam. Appl. Toxicol. 19, 336-342.
33. Waller, P.A., Clauw, D., Cupps, T., Metcalf, J.S., Silver, R.M., LeRoy, E.G., 1994. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J. Rheumatol. 21, 1567-1570.
34. Yanez Diaz, S., Moran, M., Unamuno, P., Armijo, M., 1992. Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology 184, 98-102.